FIELD: organic chemistry, medicine and experimental pharmacology.
SUBSTANCE: group of inventions relates to a new compound with osteoprotective activity. The pharmacological compound of 2-ethyl-6-methyl-3-hydroxypyridinium N-acetyl-6-aminohexanoate and 2-ethyl-6-methyl-3-hydroxypyridinium 3-pyridinocarbonoate, in a ratio of 1:3, C62H94N8O15, compound 1, which has osteoprotective activity is disclosed. Also the following is disclosed: the use of the above-mentioned pharmacological compound 1, which provides effective correction and prevention of osteoporosis.
Compound 1
EFFECT: group of inventions provides effective correction and prevention of osteoporosis.
2 cl, 4 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CORRECTING OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM HYDROXYBUTANEDIOATE IN EXPERIMENT | 2021 |
|
RU2775439C1 |
METHOD FOR THE CORRECTION OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 3-HYDROXY-2-ETHYL-6-METHYLPYRIDINIUM NICOTINATE IN EXPERIMENT | 2021 |
|
RU2763011C1 |
METHOD FOR RESERVATROL-BASED OSTEOPOROSIS CORRECTION AND FRAGILITY FRACTURE PREVENTION | 2010 |
|
RU2437161C1 |
METHOD FOR RESERVATROL AND ENALAPRIL BASED OSTEOPOROSIS CORRECTION AND FRAGILITY FRACTURE PREVENTION | 2010 |
|
RU2437160C1 |
COMPLEX SALTS OF ACIDUM ACEXAMICUM, STIMULATING REGENERATION OF BONE TISSUE, ACCELERATING PROCESSES OF REPARATIVE OSTEOGENESIS, STIMULATING MINERALIZATION OF BONE TISSUE IN OSTEOPOROSIS | 2018 |
|
RU2668966C1 |
METHOD FOR CORRECTING MICROCIRCULATORY DISORDERS WITH 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM 5-HYDROXY-3-PYRIDINOCARBONATE IN EXPERIMENTAL NMDA-MEDIATED EXCITOTOXICITY IN THE RETINA | 2022 |
|
RU2784350C1 |
METHOD FOR CORRECTING BONE MICROCIRCULATION ACCOMPANYING OSTEOPOROSIS AND UNDERLYING FRACTURES WITH USE OF COMBINATION OF L-ARGININE AND LOSARTAN | 2013 |
|
RU2542425C1 |
METHOD FOR ROSUVASTATIN CORRECTION OF BONE MICROCIRCULATION IN EXPERIMENTAL OSTEOPOROSIS AND ACCOMPANYING FRACTURES | 2013 |
|
RU2538612C1 |
METHOD FOR CORRECTION OF BONE TISSUE MICROCIRCULATON IN EXPERIMENTAL OSTEOPOROSIS AND ASSOCIATED FRACTURES WITH COMBINATION OF RECOMBINANT ERYTHROPOIETIN AND ROSUVASTATIN | 2013 |
|
RU2541184C1 |
METHOD OF OSTEOPOROSIS CORRECTION AND PREVENTION OF OSTEOPOROTIC FRACTURES BY MEANS OF LOSARTAN | 2008 |
|
RU2369391C1 |
Authors
Dates
2023-10-26—Published
2023-02-06—Filed